Review
doi: 10.1056/NEJMcp1106637.
Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms
Affiliations
- PMID: 22808960
- DOI: 10.1056/NEJMcp1106637
Item in Clipboard
Review
Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms
N Engl J Med.
.
Erratum in
- N Engl J Med. 2012 Aug 16;367(7):681
No abstract available
Comment in
-
Benign prostatic hyperplasia and lower urinary tract symptoms.N Engl J Med. 2012 Oct 25;367(17):1668; author reply 1668-9. doi: 10.1056/NEJMc1209907. N Engl J Med. 2012. PMID: 23094741 No abstract available.
Similar articles
-
Treatment of benign prostatic hyperplasia.Rev Assoc Med Bras (1992). 2017 Feb;63(2):95-99. doi: 10.1590/1806-9282.63.02.95. Rev Assoc Med Bras (1992). 2017. PMID: 28355368 No abstract available.
-
[Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].Prog Urol. 2012 Dec;22(16):977-88. doi: 10.1016/j.purol.2012.10.001. Epub 2012 Nov 6. Prog Urol. 2012. PMID: 23178093 French.
-
Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis.Eur Urol. 2017 Apr;71(4):570-581. doi: 10.1016/j.eururo.2016.09.032. Epub 2016 Oct 4. Eur Urol. 2017. PMID: 27717522 Free PMC article. Review.
-
Combination therapy for non-neurogenic male lower urinary tract symptoms: 1 + 1 does not equal 2.Eur Urol. 2013 Aug;64(2):244-6; discussion 246-7. doi: 10.1016/j.eururo.2013.02.021. Epub 2013 Feb 19. Eur Urol. 2013. PMID: 23473577 No abstract available.
-
Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?Curr Opin Urol. 2014 Jan;24(1):21-8. doi: 10.1097/MOU.0000000000000007. Curr Opin Urol. 2014. PMID: 24231531 Review.
Cited by
-
A real-world evidence study of interhospital variability in the surgical treatment of patients with benign prostatic hyperplasia: the REVALURO study.Int Urol Nephrol. 2024 Oct 29. doi: 10.1007/s11255-024-04239-7. Online ahead of print. Int Urol Nephrol. 2024. PMID: 39470938
-
NOSTRIN is involved in benign prostatic hyperplasia via inhibition of proliferation, oxidative stress, and inflammation in prostate epithelial cells.Transl Androl Urol. 2024 Sep 30;13(9):2055-2069. doi: 10.21037/tau-24-209. Epub 2024 Sep 24. Transl Androl Urol. 2024. PMID: 39434759 Free PMC article.
-
Zhuangyao Jianshen pill ameliorates testosterone-induced benign postatic hyperplasia in rats.J Tradit Chin Med. 2024 Aug;44(4):694-702. doi: 10.19852/j.cnki.jtcm.20240627.001. J Tradit Chin Med. 2024. PMID: 39066530 Free PMC article.
-
Risk factors associated with the severity of overactive bladder among Syrian patients with type 2 diabetes.Sci Rep. 2024 Jul 17;14(1):16547. doi: 10.1038/s41598-024-67326-w. Sci Rep. 2024. PMID: 39020001 Free PMC article.
-
The relationship between complete blood cell count-derived inflammatory biomarkers and benign prostatic hyperplasia in middle-aged and elderly individuals in the United States: Evidence from NHANES 2001-2008.PLoS One. 2024 Jul 9;19(7):e0306860. doi: 10.1371/journal.pone.0306860. eCollection 2024. PLoS One. 2024. PMID: 38980876 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
